Name (Synonyms) | Correlation | |
---|---|---|
drug2580 | UC-MSCs Wiki | 0.45 |
drug1822 | Placebo Wiki | 0.06 |
There is one clinical trial.
The objective: to study the efficacy and safety of levilimab in subjects with severe COVID-19.
Description: The proportion of deaths in each group
Measure: Mortality rate Time: Day 60Description: 1. Death; 2. Hospitalized, requiring invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3. Hospitalized, requiring non-invasive ventilation or high flow oxygen devices; 4. Hospitalized, requiring supplemental oxygen; 5. Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care; 6. Hospitalized, not requiring supplemental oxygen; 7. Not hospitalized / discharged
Measure: 7-point Ordinal Scale Time: Day 60